DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 168 filers reported holding DIPLOMAT PHARMACY INC in Q2 2016. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $32,000 | -50.8% | 8,070 | -38.9% | 0.00% | – |
Q3 2019 | $65,000 | -15.6% | 13,210 | +3.9% | 0.00% | -100.0% |
Q2 2019 | $77,000 | +7600.0% | 12,710 | +16846.7% | 0.00% | – |
Q2 2018 | $1,000 | 0.0% | 75 | 0.0% | 0.00% | – |
Q1 2018 | $1,000 | -83.3% | 75 | -71.2% | 0.00% | – |
Q4 2017 | $6,000 | +200.0% | 260 | +246.7% | 0.00% | – |
Q3 2017 | $2,000 | +100.0% | 75 | +36.4% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 55 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | -85.7% | 55 | -77.8% | 0.00% | – |
Q3 2016 | $7,000 | -86.8% | 248 | -84.2% | 0.00% | -100.0% |
Q2 2016 | $53,000 | +152.4% | 1,565 | +106.2% | 0.00% | – |
Q1 2016 | $21,000 | +5.0% | 759 | +31.3% | 0.00% | – |
Q4 2015 | $20,000 | +300.0% | 578 | +210.8% | 0.00% | – |
Q3 2015 | $5,000 | -37.5% | 186 | -38.0% | 0.00% | – |
Q4 2014 | $8,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
Investors Research Corp | 89,727 | $546,000 | 0.28% |
Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |